Skip to main navigation Skip to search Skip to main content

Overcoming Ganetespib Resistance to Combat Refractory HER2+ Breast Cancer

Project: Research

Project Details

StatusActive
Effective start/end date01/1/2312/31/26

Funding

  • American Cancer Society: $792,000.00